{"url":"https://lda.senate.gov/api/v1/filings/366ed1d0-8908-4fca-9dc2-e6fae4351946/","filing_uuid":"366ed1d0-8908-4fca-9dc2-e6fae4351946","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2023,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/366ed1d0-8908-4fca-9dc2-e6fae4351946/print/","filing_document_content_type":"text/html","income":null,"expenses":"990000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jon Causey","dt_posted":"2023-04-20T21:40:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"701 PENNSYLVANIA AVENUE, NW #715","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":48725,"url":"https://lda.senate.gov/api/v1/registrants/48725/","house_registrant_id":34510,"name":"BIOGEN","description":null,"address_1":"801 Pennsylvania Ave, NW, Suite 815","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JON CAUSEY","contact_telephone":"+1 202-450-7459","dt_updated":"2026-07-30T12:57:38.109676-04:00"},"client":{"id":155476,"url":"https://lda.senate.gov/api/v1/clients/155476/","client_id":12,"name":"BIOGEN","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, screening and diagnosis, PET scan coverage and reimbursement, and dementia care Inflation Reduction Act implementation, including provisions related to corporate taxes, Medicare, and prescription drug pricing Mental Health Workforce Expansion The Mental Health Professionals Workforce Shortage Loan Repayment Act HELP Copays Act Issues related to ALS","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73432,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"CAUSEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71551,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"RAYMOND","last_name":"GIBSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139808,"prefix":"mx","prefix_display":"MX.","first_name":"ALI","nickname":null,"middle_name":null,"last_name":"LAKHANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":135591,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"HARDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141617,"prefix":"ms","prefix_display":"MS.","first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"KONKA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":111813,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"HANSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Drug cost and pricing policy issues Issues regarding coverage, coding, and reimbursement issues Issues regarding Alzheimer's treatments Issues related to the 340B program","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":135591,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"HARDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141617,"prefix":"ms","prefix_display":"MS.","first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"KONKA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Drug cost and pricing policy S.127, Pharmacy Benefit Manager Transparency Act and other PBM reforms Discussions regarding pharmaceutical issues related to supply chain","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73432,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"CAUSEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":135591,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"HARDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141449,"prefix":"mr","prefix_display":"MR.","first_name":"AARON","nickname":null,"middle_name":"NICHOLAS","last_name":"BADIDA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141617,"prefix":"ms","prefix_display":"MS.","first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"KONKA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to tax reform and tax policy Implementation of Tax Cuts and Jobs Act of 2017 (P.L.115-97) Research and Development Tax Credit American Innovation and Jobs Act Tax Provisions of Budget Reconciliation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":135591,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"HARDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73432,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"CAUSEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Trade-related aspects of Intellectual Property (TRIPS) Waiver, no related bill number","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":135591,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"HARDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Appropriations on mental health screening and diagnosis","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":135591,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"HARDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Support stronger IP and exclusivity protections and enforcement in foreign markets","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":135591,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"HARDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}